Company Overview and News

 
Dividend/Distribution - CL1

2016-04-18 asx.com.au

 
Class - 31 March 2016 Update

2016-04-05 asx.com.au

 
Friends' Reunion: How the TV Show Made Them Stars and Insanely Rich - Fortune

2016-04-04 fortune
Turn off your phone, ignore the doorbell and clear your social calendar. On Sunday, the cast of the beloved NBC sitcom “Friends” will reunite.

 
How tall was Ronnie Corbett? Comedy giant was never afraid to make fun of his own height - Mirror Online

2016-03-31 mirror.co.uk
It has been announced that Ronnie Corbett has passed away at the age of 85, surrounded by his family.

 
Notice of Meetings

2016-03-22 londonstockexchange
THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF CLASS A NOTEHOLDERS AND CLASS B NOTEHOLDERS.  IF CLASS A NOTEHOLDERS OR CLASS B NOTEHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD CONSULT THEIR OWN INDEPENDENT PROFESSIONAL ADVISERS AUTHORISED UNDER THE FINANCIAL SERVICES AND MARKETS ACT 2000 IMMEDIATELY.

 
If You Purchased Certain Glucosamine and Chondroitin Joint Supplements Manufactured by Rexall Sundown, You Can Receive Money from a Class Action Settlement

2016-03-17 multivu
PR Newswire, Philadelphia, PA, March 17, 2016 The following statement is being issued by Bonnett, Fairbourn, Friedman & Balint, P.C, Boodell & Domanskis, LLC and Denlea & Carton LLP regarding the Pearson, et al. v. NBTY, Inc. settlement.

 
Notice of Meetings XS0248216680

2016-03-16 londonstockexchange
THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF CLASS A NOTEHOLDERS AND CLASS B NOTEHOLDERS.  IF CLASS A NOTEHOLDERS OR CLASS B NOTEHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD CONSULT THEIR OWN INDEPENDENT PROFESSIONAL ADVISERS AUTHORISED UNDER THE FINANCIAL SERVICES AND MARKETS ACT 2000 IMMEDIATELY.

 
Class - 100,000 Portfolios

2016-03-02 asx.com.au

 
PMA Class of 2016 is the smallest batch in decades

2016-02-19 newsinfo.inquirer.net
BAGUIO CITY, Philippines—The Philippine Military Academy (PMA) "Gabay Laya" (Guardians of Freedom) Class of 2016 is the smallest batch in decades with only 63 cadets less than a month

 
 
17-year-old gangraped, found dead near UP CM’s house

2016-02-16 freepressjournal.in
Lucknow: A 17-year-old girl, who had been missing for the last five days, has been found murdered, allegedly after being gang-raped, near Chief Minister Akhilesh Yadav’s official residence. The Class 12 student of the Rani Laxmi Bai College had been missing since Wednesday morning when she went to give her board exams.

 
Panera Bread (PNRA) Ronald M. Shaich on Q4 2015 Results - Earnings Call Transcript

2016-02-10 seekingalpha
Panera Bread Co. (NASDAQ:PNRA)Q4 2015 Earnings CallFebruary 10, 2016 8:30 am ETExecutivesSteve W. West - Vice President-Investor RelationsRonald M. Shaich - Fou

 
CL1 Interim Dividend

2016-02-09 asx.com.au

 
Appendix 4D and Half Year Report

2016-02-09 asx.com.au

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

16h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

16h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...